# Polaryx Therapeutics, Inc.: Form 8-K, filed Sep 14, 2026

- Company: [Polaryx Therapeutics, Inc.](/companies/plyx.md) (CIK 2075320)
- Form: 8-K
- Filed: 2026-09-14
- Accepted by EDGAR: Sep 11, 2026, 19:59 ET
- Period: 2026-09-10
- Accession: 0001213900-26-099416
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm

Filed Sep 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-099416. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.